28/12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

28/12/2024

Dec 28, 2024, 15:55 | Science
Chris Boerner: The FDA approved our new subcutaneous immunotherapy treatment
Chris Boerner, Board Chair and Chief Executive Officer at Bristol Myers Squibb, posted on LinkedIn:…
Dec 28, 2024, 15:46 | Science
Vivek Subbiah: Our paper on the development of PROTAC degraders of oncogenic RET protein
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Dec 28, 2024, 15:46 | Drugs
Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Dec 28, 2024, 15:14 | Blog
Can clinical trials transform cancer care? - UICC
Union for International Cancer Control (UICC) posted on LinkedIn: "Can clinical trials transform cancer care? Nina,…
Dec 28, 2024, 14:29 | Blog
Matthias Dietzel: What is the impact of prostate imaging quality?
Matthias Dietzel, Deputy Editor in Chief and Social Media Editor at Elsevier, shared a post…
Dec 28, 2024, 14:25 | Blog
The IASLC’s Hot Topic in Basic and Translational Science: SCLC has extended the abstract submission deadline
IASLC shared a post on LinkedIn: “Great News for Researchers! The IASLC’s Hot Topic in…
Dec 28, 2024, 14:23 | Blog
Cynthia Jordan: How to learn about and find breast cancer clinical trials
Cynthia Jordan , Founder and CEO at Learn Look Locate, shared a post on LinkedIn:…
Dec 28, 2024, 14:09 | Science
The new NCCN guidelines for immunotherapy-related toxicities
Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a…
Dec 28, 2024, 14:04 | Blog
Francisco Conesa Buendía: FAS-Less Allogeneic CAR-T Cells - A Leap Towards Off-the-Shelf Cancer Therapies
Francisco Conesa Buendía, Assistant in Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Dec 28, 2024, 13:49 | Insight
Timothée Olivier: What is the best 1st line immunotherapy regimen for patients with advanced/meta melanoma?
Timothée Olivier, Medical oncologist at the Oncology Division of Geneva University, shared a recent article…
All: 85 Posts: 51 - 60
Special Coverage